Substantia nigra degeneration in spinocerebellar ataxia 2 and 7 using neuromelanin‐sensitive imaging
2025

Substantia Nigra Degeneration in Spinocerebellar Ataxia 2 and 7

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lydia Chougar, Giulia Coarelli, François‐Xavier Lejeune, Pia Ziegner, Rahul Gaurav, Emma Biondetti, Sabrina Sayah, Rania Hilab, Alain Dagher, Alexandra Durr, Stéphane Lehéricy

Primary Institution: Institut du Cerveau–Paris Brain Institute ICM, Sorbonne Université

Hypothesis

The study aimed to characterize substantia nigra degeneration in SCA2 and SCA7 using neuromelanin-sensitive imaging.

Conclusion

Neuromelanin-sensitive imaging provides biomarkers of nigral degeneration in SCAs, detectable from the preataxic stage in SCA2.

Supporting Evidence

  • SCA2 participants had lower SNR values in the SNc than controls.
  • SNR in SCA7 participants and controls did not differ.
  • Signal decrease was detected at the preataxic stage in SCA2.
  • SCA2 participants showed prominent involvement of the associative and limbic nigral territories.
  • SNR discriminated ataxic and preataxic SCA2 participants from controls.

Takeaway

This study looked at brain changes in people with certain types of ataxia, finding that changes can be seen even before they show symptoms.

Methodology

Participants included SCA2 and SCA7 carriers and healthy controls, with imaging data analyzed for signal-to-noise ratios and volumes of the substantia nigra.

Limitations

The small sample size may have reduced statistical power and increased measurement variability.

Participant Demographics

15 SCA2 patients, 15 SCA7 patients, and 10 healthy controls, with no significant differences in age or sex.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 0.89–1

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1111/ene.70035

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication